title: The pharmacokinetic analysis of cyclosporine is essential for the management of refractory pure red cell aplasia.
authors: Yuichi
authors: Y
authors: Kato
authors: Katsushi
authors: K
authors: Tajima
authors: Ikuko
authors: I
authors: Suzuki
authors: Kei
authors: K
authors: Kohno
authors: Yuki
authors: Y
authors: Hiroshima
authors: Takeo
authors: T
authors: Kato
mesh_terms: D000328:Adult; D000740:Anemia / Q000209:etiology / Q000517:prevention & control; D002626:Chemistry, Pharmaceutical; D016572:Cyclosporine / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D004351:Drug Resistance; D004655:Emulsions; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D060046:Maintenance Chemotherapy; D008297:Male; D008875:Middle Aged; D057285:Precision Medicine; D012010:Red-Cell Aplasia, Pure / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology / Q000517:prevention & control; D055502:Secondary Prevention; D016896:Treatment Outcome
chemical_list: D004655:Emulsions; D007166:Immunosuppressive Agents; D016572:Cyclosporine